Ascend Biopharmaceuticals Ltd
3 clinical trials · Sponsor
◉ Watch Ascend Biopharmaceuticals Ltd
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor (NCT04416516) | Ascend Biopharmaceuticals Ltd | 2020-07-16 |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) (NCT03208296) | Ascend Biopharmaceuticals Ltd | 2017-12-01 |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma (NCT02550678) | Ascend Biopharmaceuticals Ltd | 2015-09-01 |
Track Ascend Biopharmaceuticals Ltd automatically
Every clearance here is in the API, with alerts when new ones post.